Circulating tumor DNA (ctDNA) analysis over the short term did not demonstrate a difference between study arms. Gritstone bio priced the approximately $32.5 million underwritten public offering. The ...

Bio-Rad Laboratories, Inc. is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, ...

On Tuesday, SAB BIO (NASDAQ:SABS) released topline data from a Phase 1 trial of SAB-142 in a single-ascending dose among healthy volunteers. The study met its primary safety and pharmacodynamic ...

Cabaletta didn't have any major announcements or any Securities and Exchange Commission (SEC) filings to make the stock rise. However, Guggenheim initiated coverage of the stock, with a price target ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--2seventy bio, Inc. (Nasdaq: TSVT), a leading immuno-oncology cell therapy company, announced today that the Company will host a conference call on Tuesday, December ...

HOLMDEL, N.J., March 25, 2026 (GLOBE NEWSWIRE)-- BIO-key International, Inc. (NASDAQ: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, will ...

We recently published a list of Tuesday’s 10 Worst-Performing Stocks. In this article, we are going to take a look at where ImmunityBio Inc. (NASDAQ:IBRX) stands against other Tuesday’s ...

HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, announced today that the company’s ...

The MarketWatch News Department was not involved in the creation of this content. HOLMDEL, N.J., March 25, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), a global leader in ...

Source: Bio-Rad Laboratories, Inc. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Sign up for our newsletter to ...